Xin Zhang – Trademark Portfolio
Entity Type: 01
Xin Zhang owns a portfolio of 45 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as EITHY, LCVME, ALPACA, FLAZEY, and GVRSLM. Of these, 25 are registered and 13 are pending. The portfolio spans 13 Nice Classification classes, led by Class 25 (Clothing) and Class 28 (Toys & Sporting Goods). Headquartered in Hunan Province.
Honghe Group, Changqing Community
Baiguo Town, Hengshan County
Hunan Province 421300 , CN
Showing of trademarks Trademarks
Trademark Classifications
Xin Zhang's trademark portfolio spans 13 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Xin Zhang have?
Xin Zhang has 45 U.S. trademarks filed with the USPTO. Of these, 25 registered, 13 pending, 7 abandoned.
What trademark classes does Xin Zhang file in?
Xin Zhang files trademarks across 13 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 28 (Toys & Sporting Goods), Class 5 (Pharmaceuticals), Class 43 (Hotels & Restaurants), Class 9 (Computers & Electronics). Class 25 covers clothing, footwear, headgear.
What are Xin Zhang's most well-known trademarks?
Xin Zhang's registered trademark portfolio includes well-known marks such as EITHY, LCVME, ALPACA, FLAZEY, and GVRSLM. These are among 25 currently registered trademarks in the portfolio.
What is Xin Zhang's trademark registration success rate?
Xin Zhang has a 78% trademark registration rate, with 25 out of 32 resolved applications resulting in successful registration. Currently, 13 applications are pending review.